3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Dermatologic
1
Conditions
Mycosis Fungoides
2
Carcinoma, Non-Small-Cell Lung
2
Sezary Syndrome
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Primary Cutaneous Anaplastic Large Cell
1
Lymphoma
1
Interventions
Methotrexate
1
Brentuximab Vedotin
1
Bexarotene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Lymphoma, Primary Cutaneous Anaplastic Large Cell
×
Bexarotene
×
Clear all
NCT01578499
2021-01-05
ALCANZA
Takeda
Phase 3
Completed
131 enrolled
24 charts